Remove Marketing Remove Packaging Remove Webinar
article thumbnail

Webinar: Making Sense of Technology Landscapes

Translation

Missed the webinar or wish to revisit the discussion? We work with Global 1,000 and Fortune 500 companies and leverage networks of PhD scientists, subject matter experts, and artificial intelligence to create business actionable intelligence that incorporates technologies and market strategy. Kevin Leland: Gotcha.

article thumbnail

Developing and Manufacturing Minitablets to Extend Drug Lifecycle

Fierce BioTech

Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article Periodic Thank You Commission unveils “one substance, one assessment” reform package

Agency IQ

Commission unveils “one substance, one assessment” reform package The Commission has long aspired to realize its one substance, one assessment concept in the EU’s chemical regulatory regime. An observatory will also be created that publicly compiles information on the properties, uses, and market presence of certain chemicals.

article thumbnail

Article EMA Thank You What we expect European regulators to do in November 2023

Agency IQ

A wide range of other meetings that will be occurring this month, with various webinars, committee meetings, and workshops spanning a variety of topics. Upcoming Webinar Hosted by Xtalks Webinar/Seminar ( OPEN) Xtalks 11/6/2023 11/6/2023 What is the evidence for high-risk medical devices in the field of cardiovascular disease and diabetes?

article thumbnail

Article EMA Thank You What we expect European regulators to do in June 2024

Agency IQ

Many of these webinars and trainings sessions are geared towards medical devices and in vitro diagnostics (IVDs). Even small changes in the Parliament’s composition could have an impact on ongoing legislative discussions, such as the revisions to the pharma reform package.

article thumbnail

Article EMA Thank You What we expect European regulators to do in May 2024

Agency IQ

Many of these are webinars and/or trainings sessionsfor new digital platforms. The pharma reform package remains in E.U. In the interim, the European Council will continue to discuss the package, and stakeholders may gain some insight into the Council’s thinking near the end of May. On April 10, the E.U.

article thumbnail

Article EMA Thank You What we expect European regulators to do in August and September 2024

Agency IQ

Major European regulators, national competent authorities, and interest groups are planning on hosting several webinars and trainings throughout August and September. Speaking of policy, legislative affairs will also likely pick up.